Endpoints News company information, Employees & Contact Information

More than a third of Lilly's new Zepbound prescriptions are coming from DTC program Endpoints News

'Poor children of very rich parents': How Verily plans to grow out of Alphabet's shadow Endpoints News

Sironax Named to 2025 Endpoints 11 List of the Most Promising Biotech Startups Yahoo Finance

End­points News is get­ting a new web ad­dress: https://end­points.news Endpoints News

First impressions on the ground at HLTH 2025 Endpoints News

A $6B bet to change drug pricing Endpoints News

We’re doing a Health Tech meet-up in NYC — see you there? Endpoints News

Thyme Care hits $1B valuation in latest funding round Endpoints News

Exclusive: At-home screening startup Reperio Health raises $14M Endpoints News

Preventive health startup Superpower raises $30M Endpoints News

Omada Health joins the digital health IPO corral Endpoints News

Walgreens turns on dark mode Endpoints News

OpenAI meets cancer care Endpoints News

Updated: To spin off or not to spin off? Galapagos backpedals on separation plans, CEO Paul Stoffels exits early Endpoints News

Big ambitions at Merck and AstraZeneca — along with a few giant pitfalls — reshape top ranks of the R&D 15 Endpoints News

In one of the riskiest industries — Biotech — a surefire way to neutralize some of that risk emerges Endpoints News

Will CRISPR matter? Endpoints News

New study will try to stop Alzheimer’s decades before it begins, using experimental Eli Lilly drug Endpoints News

China's biotech boom is threatening US drugmakers' dominance Endpoints News

Exclusive: First-of-its-kind infant DNA edit leads to apparent cure in disease that set back field 25 years ago Endpoints News

Exclusive: Movement disorder biotech Vima steps onto scene with $60M Endpoints News

Lonza says its US-based sites are in high demand as pharma tariffs near Endpoints News

#JPM25 live blog day 2: Nvidia makes it fun; The year's 10th megaround Endpoints News

How AI can address ongoing challenges in the life sciences industry Endpoints News

Primate researchers cope with uncertainty as NIH appeals for payment cuts in court Endpoints News

FDA will consolidate to five 'shared services offices,' according to memo to Hill staffers Endpoints News

Novo Nordisk adjusts its leadership team; Dyne alums migrate to Crescent Biopharma Endpoints News

Exclusive: Drug compounder Empower was built on risky shortcuts, ex-employees and inspections allege Endpoints News

China startup injects CRISPR therapy into the brain for the first time Endpoints News

Exclusive: Employer healthcare company Personify Health says it has $500M+ in revenue, is 'highly' profitable Endpoints News

Thousands of gene and cell therapies are inundating FDA reviewers as the agency tries to keep up Endpoints News

Exclusive: Infectious disease doctors consider 'mini-ACIP' if RFK erodes CDC vaccine panel Endpoints News

Ozempic makes list for next round of Medicare drug price negotiations Endpoints News

Where the money is: The top 100 venture investors in biotech Endpoints News

Sarepta shares two-year DMD study data that could inform European approval decision Endpoints News

Updated: Drug prices likely to soar due to Trump tariffs, pharma bodies warn Endpoints News

Webinar on drug development in Japan attracts 1,700 industry leaders | Global Services | Nikkei Inc. nikkei.co.jp

Updated: Biogen makes cuts across its research unit, shifting focus to ‘external opportunities’ Endpoints News

Is the GLP-1 compounding boom over? Not exactly Endpoints News

FDA approves Ionis’ treatment for a rare metabolic disorder Endpoints News

Profluent debuts AI model for CRISPR design, hoping to expand gene editing's potential Endpoints News

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs Endpoints News

Endpoints News names the 11 most promising biotech startups of 2021 PR Newswire

Endpoints News Announces the 2024 Winners of the Endpoints 11 Awards, Highlighting Biotech’s Most Promising Startups Business Wire

Financial Times Acquires Majority Stake in Endpoints News Business Wire

Next-gen therapies are evolving fast. The drug development model needs to keep up Endpoints News

Special report 2024: Meet 20 women breaking new ground in biopharma R&D Endpoints News

Zocdoc’s CEO shares how the 16-year-old company weathered Covid-19, and why some startup ideas fail Endpoints News

Endpoints News Announces the 2023 Winners of the Endpoints 11 Awards, Highlighting Biotech’s Most Promising Startups Business Wire

Exclusive: Komodo is betting that its newest tool can upend how healthcare data are analyzed and used Endpoints News

Hims CEO says he’d rather go after rivals’ customers than buy their businesses Endpoints News

Exclusive: Terray raises $120M for its AI ways of designing molecules Endpoints News

Scientists alarmed about future of cancer research; TIGIT, CAR-NK and more from #AACR25 Endpoints News

Why the president of Kroger Health is betting the grocery giant can use food as medicine Endpoints News

Endpoints News Announces Women in Biopharma 2022 Winners Business Wire

CMIC: Japan’s leading CRO focuses on the future of clinical trials with innovation and digital solutions Endpoints News

The Endpoints 11 winners: Big bets on AI, new frontiers in editing, a neuro renaissance and Chinese chemistry Endpoints News

Synaffix, industry's ADC partner of choice, spins out a startup pipeline Endpoints News

How you access Endpoints News is changing Endpoints News

Endpoints News Announces New Editorial Hires in Coverage Expansion Business Wire

General Catalyst’s Daryl Tol lays out why he thinks he can help health systems transform themselves Endpoints News

Endpoints News announces its Women in Biopharma 2020 winners - live event to be held today PR Newswire

GSK to spend $800M to build two vaccine factories in the US Endpoints News

Endpoints 11 winner Capstan Therapeutics: Trying to win the in vivo CAR-T race Endpoints News

Endpoints News Appoints Ryan McRae as Chief Revenue Officer Business Wire

FDA approves Novartis’ Fabhalta in another rare kidney disease Endpoints News

Bloomberg’s Drew Armstrong Joins Endpoints as Executive Editor to Lead Expansion Business Wire

Q&A: GSK CSO Tony Wood on staying out of obesity, 'careful' cancer ambitions, and AI's future in R&D Endpoints News

Endpoints News to hold its first annual Women in Biopharma 2020 event, recognizing this year's top 20 women in drug R&D PR Newswire

Exclusive: J&J folds cardiovascular and metabolic drug unit Endpoints News

FogPharma rebrands as Parabilis Medicines, as CEO Mathai Mammen highlights next drugs Endpoints News

Exclusive: In $1B+ bet on AI, biopharma heavyweights back new startup to upend drug R&D Endpoints News

Circle Pharma raises $54M as part of Series D while macrocycles heat up Endpoints News

TTP Introduces Cellular Origins, a TTP Company Focused on Delivering Scalable Manufacture of Cell and Gene Therapies Technology Networks

Biohaven Advances Development of the MoDE Platform Technology Licensed From Yale University PR Newswire

Third Rock and Arie Belldegrun’s firm come together for CD20/CD3 bispecific out of China Endpoints News

Secretive Treeline Biosciences discloses $421M financing in filing Endpoints News

Inside the race to make psychedelics ‘mainstream medicines’ Endpoints News

A teenager faced constant seizures. Could a drug developed just for him stop them? Endpoints News

Lilly quietly completes purchase of Padcev competitor, estimated at nearly half a billion dollars Endpoints News

Analysis: In most of the Big Pharma world, R&D spending towers over revenue from new drugs. Guess who beat the odds Endpoints News

Longevity investors look to add $200M to the table with new growth fund Endpoints News